Pharmacogenetics

26
PHARMACOGENETICS ALMAS MUHAMMAD ARSHAD Roll No. 01

Transcript of Pharmacogenetics

Page 1: Pharmacogenetics

PHARMACOGENETICS

ALMAS MUHAMMAD ARSHAD

Roll No. 01

Page 2: Pharmacogenetics

Introduction: Pharmacogenetics = Pharma and genetics• Pharma is derived from the Greek word i.e.

PHARMACON, related to Drugs.• Genetics means related to genes / genome.

Now known as “PHARMACOGENOMICS”

Page 3: Pharmacogenetics

Definition:

“..It is the branch of Pharmacology, that deals with the altered drug response shown due to variation in the Genetics..”

Page 4: Pharmacogenetics

What are Genetic Variations?

Are described as naturally occurring genetic differences among individuals of the same species.

Occur during crossing over of DNA during Meiosis (type of cell division).

Page 5: Pharmacogenetics

Genetic Variation (Types)

Two types of variation are common in the genome:

1. Changes in single letters called ‘Single nucleotide polymorphisms‘ ( SNPs)

2. Changes in DNA, can be a missing whole block of DNA (a deletion), or might have one, two, three or more copies. This is known as Copy number variation.

Page 6: Pharmacogenetics

Significance Of Pharmacogenetics:

It is significant in the modification of drug therapy with respect to the patients Genotype to:• Ensure maximum efficacy and • Minimize the adverse effects

of a drug. It lead to the development of Personalized medicine.

Page 7: Pharmacogenetics

Personalized Medicine [PM]:

Abbreviated as ‘PM’ It is the use of Pharmacogenetics to form a drug

therapy according to individual’s drug response. It increases the chances of a successful outcome and reduced possible adverse effects of a drug therapy.

Page 8: Pharmacogenetics
Page 9: Pharmacogenetics

How is tailored drug therapy useful?Tailored Drug therapy limits down the complications of altered drug response. Alterations in drug response can be dangerous.

Page 10: Pharmacogenetics

Did You Know?Studies show that every year

about 2 million people are hospitalized for drug adverse

reactions. And every year 100,000 people die because of

these reactions

This makes it the 6th leading cause of death worldwide

Complications of Altered drug response:

Unusual drug responses include accumulation of the drug in the body leading to adverse effects, that can sometimes prove fatal.

Page 11: Pharmacogenetics

we may say that ONE type of Drug cannot FIT ALL!

Page 12: Pharmacogenetics

So….

While prescribing, a drug, dosage and frequency of administration, genetic differences MUST be

considered by the physician.

Page 13: Pharmacogenetics

What Genetic variations contribute to altered

Drug response? Genetic variations are seen following protein

structures due to differences in the genes.

1. Receptors

2. Enzymes

Page 14: Pharmacogenetics

Cntd..

1. Receptors: o Cell surface proteins where the drug will bind.o Absence of receptors on the effector organ will

result in no therapeutic effect but adverse effects due to the accumulation of drug.

Page 15: Pharmacogenetics

Cntd..

2. Enzymes:

o Are globular proteins that are responsible for metabolizing drugs. o Deficiency or other defects in enzymes will result in

no drug breakdown and thus accumulation of drug in the body, showing drug’s adverse effects.

o Example: G-6-P-D deficiency, Pseudocholinesterases deficiency.

Page 16: Pharmacogenetics

Some Genetic Variations/Disorders and the altered Drug response:1. Less active or inactive

Cytochrome P450:o The system is unable to breakdown and

efficiently eliminate the drug from the body which leads to drug over-dosage and thus adverse effects in patients.

o E.g.: Slow Hydroxylation of Warfarin cause accumulation of drug and resulting in Warfarin side effects

Page 17: Pharmacogenetics

Cntd..

2. Cytochrome 2C19 Deficiency:o It is a type of P450, that are liver enzymes.o The Cytochrome 2c19 catalyzes the hydroxylation of

Mephenytoin ( i.e. an anti-epileptic drug)o Results in Mephenytoin adverse effects.Some Drugs whose metabolism is

affected by P450 Variants:o Anti-arrhythmicso Beta – Adrenergic receptor blockerso Neurolepticso Tricyclic Anti-depressantso Decongestants

Page 18: Pharmacogenetics

Cntd..

3. Pseudocholinesterases Deficiency:o An enzyme that breaks down cholines.o It’s deficiency causes increased sensitivity to certain

muscle relaxant drugs (Succinylcholine) used during general anesthesia.

o Patient will be unable to move or breathe on their own for a few hours after the drugs are administered.

o Incidence of this deficiency is 1/3000 patients.

Page 19: Pharmacogenetics

Cntd..

4. Glucose-6-Phosphate Dehydrogenase Deficiency:

o It is an enzyme that converts Glutathione to a reduced form, that keeps membrane proteins in operative condition.

o Deficiency leads to altered cell membrane and thus causing hemolysis on administration of some drugs like Anti-malarial, Sulphonamides, Analgesics, Sulphones etc

Page 20: Pharmacogenetics

Cntd..

5. Vitamin D Resistance:o X-linked genetic variation o Patient fails to metabolize Vitamin D to it’s active

form and develop Vitamin D resistant rickets.

Page 21: Pharmacogenetics

Cntd..

6. Acetylation:o Defect is less synthesis of N-acetyltransferase

(liver) Slow Acetylation. Rest, Fast Acetylators!o Slow Acetylation may lead to higher blood levels

of the drug and thus, result in toxic effects.o Drugs Metabolized by Acetylation:

IsoniazidProcainamide (antiarrhythmic)Sulfa drugs (e.g. sulfonamide antibiotics)Dapsone (anti-leprosy, antiparasitic)

Page 22: Pharmacogenetics

Cntd..

7. Malignant Hyperpyrexia: Autosomal Dominant Disorder Mutation of the Ryanodine receptor, located on

sarcoplasmic reticulum mediate the release of calcium ions resulting in a drastic increase in intracellular calcium thus, muscle contraction

consumes large amounts of ATP and generates the excessive heat (hyperthermia)

Triggered by exposure to certain drugs used for general anesthesia (Halothane etc)

Page 23: Pharmacogenetics

Cntd..

8. Acatalasia o Single gene defect o Complete lack of enzyme ‘Catalase’o Hydrogen peroxide ineffective to the patient

9. Acute Intermittent Porphyriao Rare Autosomal dominant metabolic disorder o Deficiency of the enzyme ‘Porphobilinogen

deaminase’o anti-psychotics aggravate the disease.

Page 24: Pharmacogenetics

Cntd..

10. Methaemoglobinaemia:o Patient lacks the enzyme 'Methaemoglobin

reductase’ that normally prevent formation of Methaemoglobin.

o Drugs that cause Methaemoglobinaemia in this case: Sulphonamides Phenacetine Nitrates Quinones

Page 25: Pharmacogenetics

References:

Google.comWikepedia.comKatzung – Basic and Clinical Pharmacology (12th Edition)Lippincott Illustrated Review (5th Edition)Katzung & Trevors Pharmacology Review (9th Edition)

Page 26: Pharmacogenetics

Thank You for your

Attention!

Almas Muhammad ArshadRoll No. 01